(Q36102824)
Statements
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study (English)
Javier Sastre
M Luisa Maestro
Auxiliadora Gómez-España
Fernando Rivera
Manuel Valladares
Bartomeu Massuti
Manuel Benavides
Manuel Gallén
Eugenio Marcuello
Albert Abad
Antonio Arrivi
Carlos Fernández-Martos
Encarnación González
Enrique Aranda